NFKB1 and inflammatory bowel disease: Interestingly, in UC patients, L. plantarum DNA reduced IL12B and FASLG expression, with an involvement of NF-κB and STAT1 pathways, suggesting that this probiotic strain may have an anti-inflammatory effect in this group of IBD patients (Figure 4).